Distention of the Immature Left Ventricle Triggers Development of Endocardial Fibroelastosis: An Animal Model of Endocardial Fibroelastosis Introducing Morphopathological Features of Evolving Fetal Hypoplastic Left Heart Syndrome by Shimada, Shogo et al.
Distention of the Immature Left Ventricle
Triggers Development of Endocardial
Fibroelastosis: An Animal Model of
Endocardial Fibroelastosis Introducing
Morphopathological Features of Evolving
Fetal Hypoplastic Left Heart Syndrome
The Harvard community has made this
article openly available.  Please share  how
this access benefits you. Your story matters
Citation Shimada, Shogo, Christian Robles, Ben M. W. Illigens, Alejandra
M. Casar Berazaluce, Pedro J. del Nido, and Ingeborg Friehs. 2015.
“Distention of the Immature Left Ventricle Triggers Development
of Endocardial Fibroelastosis: An Animal Model of Endocardial
Fibroelastosis Introducing Morphopathological Features of
Evolving Fetal Hypoplastic Left Heart Syndrome.” BioMed Research
International 2015 (1): 462469. doi:10.1155/2015/462469. http://
dx.doi.org/10.1155/2015/462469.
Published Version doi:10.1155/2015/462469
Citable link http://nrs.harvard.edu/urn-3:HUL.InstRepos:17295643
Terms of Use This article was downloaded from Harvard University’s DASH
repository, and is made available under the terms and conditions
applicable to Other Posted Material, as set forth at http://
nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-of-
use#LAA
Research Article
Distention of the Immature Left Ventricle Triggers
Development of Endocardial Fibroelastosis: An Animal Model of
Endocardial Fibroelastosis Introducing Morphopathological
Features of Evolving Fetal Hypoplastic Left Heart Syndrome
Shogo Shimada, Christian Robles, Ben M. W. Illigens, Alejandra M. Casar Berazaluce,
Pedro J. del Nido, and Ingeborg Friehs
Department of Cardiac Surgery, Boston Children’s Hospital, Harvard Medical School, 300 Longwood Avenue, Boston, MA 02115, USA
Correspondence should be addressed to Ingeborg Friehs; ingeborg.friehs@childrens.harvard.edu
Received 26 September 2014; Accepted 22 November 2014
Academic Editor: Oreste Gualillo
Copyright © 2015 Shogo Shimada et al.This is an open access article distributed under the Creative Commons Attribution License,
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Background. Endocardial fibroelastosis (EFE), characterized by a diffuse endocardial thickening through collagen and elastin fibers,
develops in the human fetal heart restricting growth of the left ventricle (LV). Recent advances in fetal imaging indicate that EFE
development is directly associated with a distended, poorly contractile LV in evolving hypoplastic left heart syndrome (HLHS). In
this study, we developed an animal model of EFE by introducing this human fetal LV morphopathology to an immature rat heart.
Methods and Results.Aneonatal donor heart, inwhich aortic regurgitation (AR)was created, was heterotopically transplanted into a
recipient adult rat. AR successfully induced the LVmorphology of evolving HLHS in the transplanted donor hearts, which resulted
in the development of significant EFE covering the entire LV cavity within two weeks postoperatively. In contrast, posttransplants
with a competent aortic valve displayed unloaded LVs with a trace of EFE. Conclusions. We could show that distention of the
immature LV in combination with stagnant flow triggers EFE development in this animal model. This model would serve as a
robust tool to develop therapeutic strategies to treat EFE while providing insight into its pathogenesis.
1. Introduction
Endocardial fibroelastosis (EFE), characterized by a diffuse
endocardial thickening through collagen and elastin fibers,
predominantly develops in immature left atrium (LA) and left
ventricle (LV) [1, 2]. EFE has been described in association
with a wide variety of diseases, such as viral myocarditis [3],
lysosomal storage diseases [4], idiopathic or genetic dilated
cardiomyopathies [5, 6], immunologic diseases [7, 8], and
structural cardiac malformations [9, 10], such as hypoplastic
left heart syndrome (HLHS). Although it has been speculated
that an early hemodynamic insult on the immature LV plays
a key role in the development of EFE, its precise pathogenesis
has not been elucidated [11, 12].
Recent advances in fetal imaging have demonstrated that
in a subset of HLHS patients progression of fetal aortic
stenosis occurs relatively late in gestation [13]. Fetal aortic
balloon valvuloplasty (FAV) has been successfully performed
to avert this progression in a selected patient population
[14]. The development of EFE has been well described in the
progression of this disease and has been shown to contribute
to LV growth retardation and immediate, and more likely,
long-term diastolic dysfunction [15, 16]. Disease progression
is characterized by dramatic morphological changes of the
affected LV. Initially, the LV appears normal in size with
decreased contractility; then, it develops dilation with hyper-
echogenic endocardium, indicative of EFE. Finally, later in
gestation, it progresses into a hypocontractile state with LV
hypoplasia that meets the diagnostic criteria for HLHS [17].
These clinical observations of the LV suggest that distention
is a key factor in the development of EFE. In addition, it
has been recognized that EFE is more likely to develop in
a borderline developed LV rather than a diminutive LV, the
latter being protected fromdistention since it has neither inlet
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nor outlet [16, 18, 19]. Furthermore, most of LVs developing
EFE from other etiologies are distended at the time of
EFE manifestation [1, 2, 9, 20]. Collectively, these clinical
observations implicate that distention of the immature LV
may significantly add to the severity of EFE development,
potentially on the basis of unknown intrinsic genetic or
immunologic predispositions.
Based on our hypothesis that immaturity and stagnation
of intracavitary flowwould play a key role in the development
of EFE, we reported our results on EFE development in
a heterotopically transplanted neonatal rat heart model,
where the LV had no intracavitary flow (i.e., preload) [21].
This animal model, however, showed variable degrees of
EFE formation which we could only assess at postmortem
analysis since echocardiographic evaluation was limited due
to restricted view of the intra-abdominally located donor
heart. In addition, postmortem analysis indicated a direct
correlation between the degree of EFE and ventricular
distention which was most likely a result of intraopera-
tive technical difficulties resulting in the distortion of the
aortic root. These combined observations of clinical and
experimental data indicate that additional factors contribute
to the pathophysiological mechanism of EFE formation.
Thus, we refined our hypothesis, combining immaturity and
stagnation of flow within the LV cavity with intentional LV
distention and modification of the anatomical location of
the heterotopically transplanted heart for echocardiographic
monitoring. In order to test this hypothesis, we modified the
previously described heterotopically transplanted immature
heart model by introduction of acute LV distention through
creation of severe aortic regurgitation without compromising
coronary perfusion and femoral location of the donor graft.
2. Materials and Methods
All animal procedures in this study were conducted in
accordance with the Principles of Laboratory Animal Care
formulated by the National Society for Medical Research
and the Guide for the Care and Use of Laboratory Animals
prepared by the Institute of Laboratory Animal Resources
and published by the National Institutes of Health (NIH Pub-
lication number 86-23, revised 1996). The animal protocols
were reviewed and approved by the Institutional Animal Care
and Use Committee at Boston Children’s Hospital.
2.1. Heterotopic Femoral Neonatal Rat Heart Transplantation.
Heterotopic femoral heart transplantations were performed
between syngeneic Lewis rats (Charles River Laboratories
International, Wilmington, MA) using the technique previ-
ously described with a few modifications [22]. The proce-
dures were performed under a surgical microscope (Endure
Medical, Georgia) with 6x to 40xmagnification. Donors with
AR creation served as a distended LV model (𝑛 = 10) and
thosewith an intact aortic valve served as unloaded LVmodel
(𝑛 = 14).
2.1.1. Recipient Preparation. Recipient rats (male, 150 to
200 g) were anesthetized via intraperitoneal injections of
Ketamine (40mg/kg) and Xylazine (10mg/kg). Heparin
(300 IU/kg) was also administered intraperitoneally. Anes-
thesia was maintained by isoflurane inhalation (1 to 2%)
through an endotracheal tube under mechanical ventilation
(Inspira Advanced Safety Ventilator, Harvard Apparatus,
Holliston, MA). A skin incision was made along the inguinal
crease to expose the femoral artery and vein.
2.1.2. Donor Preparation and Creation of Aortic Regurgitation.
Neonatal rats (postnatal day 2 to 4, 10 ± 2 g) served as a
donor. Anesthesia was induced in the same way as in the
recipients. The chest was opened with a V-shaped incision
to free the entire anterior rib cage for wide exposure. High
potassiumKrebs-Henseleit solution was administered via the
inferior vena cava to obtain optimal cardiac preservation and
eliminate blood. The distal ascending aorta and pulmonary
trunk were cut and divided as proximally as possible to
facilitate subsequent anastomoses. All other accessory vessels
were ligated by 7-0 nylon sutures and cut off. The aortic
valvewas either damaged by inserting an ultrathin guide-wire
(Roadrunner Extra-Support Wire Guide, diameter: 0.014
inch, COOK MEDICAL, Bloomington, IN) to create aortic
regurgitation or left intact. The harvested heart was stored in
cardioplegic solution at 4∘C.
2.1.3. End-to-End Anastomoses. Microvascular clamps were
placed on the recipient proximal femoral artery and vein
separately. The distal femoral artery and vein were tied off
before branching superficial caudal epigastric artery and vein.
The harvested donor heart was then transferred into the
recipient groin for transplantation. The donor’s ascending
aorta and pulmonary trunk were anastomosed to the recip-
ient’s femoral artery and vein, respectively, in an end-to-end
manner. The arterial anastomosis was made by 8 to 10 inter-
rupted stitches with 10-0 and 11-0 nylon sutures. The venous
anastomosis was made by continuous running suture with
an 11-0 nylon suture. After completion of the anastomoses,
the microvascular clamps were removed. The transplanted
hearts resumed beating within a minute and showed variable
distention according to the degree of aortic regurgitation.The
incision was closed following hemostasis. The recipient rat
was then given analgesics (Buprenorphine: 0.1mg/kg S.C.,
Meloxicam: 1mg/kg S.C.) and extubated.The rat was allowed
to recover and usually had no difficulty in ambulation. No
limitation on feeding was imposed perioperatively and no
antibiotics were given (Figures 1(a) and 1(b)).
2.2. Heterotopic Abdominal Rat Heart Transplantation. Con-
ventional heterotopic abdominal heart transplantations using
a 2-week-old donor with AR creation were performed as
previously described (𝑛 = 3) [23, 24]. Briefly, the donor heart
harvest and AR creation was carried out in the same way as
the femoral transplantation. The donor’s great vessels were
anastomosed to a recipient’s infrarenal abdominal aorta and
inferior vena cava, respectively, in an end-to-side manner.
Postoperative care and time course of the experiments were
the same as the femoral transplantation.
2.3. Postoperative Trans-Femoral Echocardiography. Thetrans-
planted hearts underwent echocardiographic evaluation for
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Figure 1: (a) Heterotopic femoral heart transplantation. (b) Schemes of blood circulation of transplanted hearts and representative
photographs of the posttransplants. Reduced flow through the LV in the unloaded LV model with intact aortic valve (upper row)
versus increased pressure and volume load in the distended LV model with AR creation (lower row). (c) Postoperative trans-femoral
echocardiography. Representative images from a distended LV with AR. (d) A grading system for the amount of EFE. EFE scores (Grade
0, no EFE; Grade 1, islets of EFE; Grade 2, thin EFE tissue covering a half circumference of the endocardium; Grade 3, thin EFE tissue (less
than 100𝜇m) covering a full circumference of the endocardium; Grade 4, thick EFE tissue (more than 100𝜇m) covering a full circumference
of the endocardium). White scale bar, 200 𝜇m.
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LV dimensions, contractility, and aortic valvular function
one week postoperatively. The recipient rat was anesthetized
by isoflurane inhalation (1 to 2%) delivered via a nose cone
and positioned supine on a heated platform for echocar-
diography (Vevo 2100, FUJIFILM VisualSonics, Toronto,
Canada). A long axis view of the transplanted heart was visu-
alized through an apical approach by a 40MHz transducer
(MS550D, FUJIFILM VisualSonics, Toronto, Canada). Data
were acquired via this apical long axis view (Figure 1(c)).
2.4. Histological Evaluation of the Transplanted Hearts. The
recipient rats were euthanized two weeks postoperatively.
The transplant hearts were explanted and fixed in 4%
paraformaldehyde for 24 hours, embedded in paraffin, and
sectioned to obtain either short or long axis view of the
LV. Hematoxylin and Eosin staining, Masson’s Trichrome
staining, and Elastica van Gieson staining were performed
on those sections using standard protocols to determine EFE.
The degree of EFE was graded semiquantitatively on a scale
from 0 to 4 (Grade 0, no EFE; Grade 1, islets of EFE; Grade
2, thin EFE tissue covering half of the circumference of the
LV endocardium; Grade 3, thin EFE tissue (less than 100 𝜇m)
covering the full circumference of the LV endocardium;
Grade 4, thick EFE tissue (more than 100 𝜇m) covering
the full circumference of the LV endocardium; Figure 1(d)).
Images were acquired on a microscope (Axio Observer. Z1,
Carl Zeiss Microscopy LLC, Peabody, MA).
2.5. Statistical Analysis. LV parameters of the posttransplants
from echocardiographic measurements were assessed for
group differences using an unpaired 𝑡-test. Comparisons of
EFE scores between groups were made using nonparametric
(Mann-Whitney) tests conducted with JMP (8.0.1, SAS Insti-
tute, Japan). Data are expressed as means ± SEMs. 𝑃 < 0.05
was considered statistically significant.
3. Results
3.1. AR Successfully Induced the LV Morphology of Evolving
HLHS on the Transplanted Donor Hearts. We conducted
heterotopic femoral neonatal rat heart transplantations to
test if AR creation could induce acute LV distention on the
immature neonatal donor rat heart. The transplanted hearts
with AR creation (𝑛 = 10) were compared to those with
an intact aortic valve (𝑛 = 14) via postoperative trans-
femoral echocardiography. In the distended LV model, the
LVs were markedly dilated by significant AR, whereas those
in the unloaded LV model became contracted with reduced
preload (LVDd (mm), 3.33 ± 0.47 versus 1.35 ± 0.09, 𝑃 <
0.01; LVDs (mm), 2.84 ± 0.50 versus 1.10 ± 0.12, 𝑃 < 0.01)
(Figure 2(a)). Both groups showed decreased LV contractility
without any significant difference (FS (%), 18.45 ± 3.73 versus
21.77 ± 4.22, N.S.). These echo findings indicate that AR
introduction could instantaneously alter the morphology
of the transplanted hearts due to significant pressure and
volume overload.
3.2. EFE Developed in the Distended Immature LVs. His-
tological evaluation was performed to determine if these
distended hearts developed significant EFE. In the distended
LV model with AR, the explanted hearts were larger in
size and all 10 cases developed significant EFE. In the most
severe EFE cases (EFE score 4), EFE was macroscopically
discernible as a thick white layer on the endocardial surface.
Microscopic observations confirmed a collagen-rich fibrous
tissue with elastin fibers covering the endocardial surface,
which specified EFE (Figure 3(a)). In contrast, the unloaded
LVs appeared contracted, and EFE developed only in 2 cases.
Instead, a mural thrombus was organized in 3 out of 14
unloaded LVs and distinguished from EFE by the absence
of elastin fibers (Figures 3(b) and 3(c)). EFE scores in the
distended LV model were significantly higher than those in
the unloaded LV model (2.90 ± 0.26 versus 0.29 ± 0.21, 𝑃 <
0.01) (Figure 3(d)).
EFE develops almost exclusively in the early stage of life.
We, therefore, performed the distended LV model using a
relatively mature donor (2-week-old, 𝑛 = 3) (Figures 4(a)
and 4(b)). In this model, none of the transplanted hearts
developed EFE, and fibrosis was mainly distributed in the
subendocardial layer instead of the endocardial surface
(Figure 4(c)).
3.3. EFE Increased in Proportion to the Severity of LV Disten-
tion. Although all the distended LVs developed significant
EFE, its degree varied. To further clarify the relationship
between distention and EFE development, we compared echo
data between the most severe EFE cases (Grade 4, 𝑛 = 3)
and the others (Grade 2 and 3, 𝑛 = 7) from the distended LV
model. Echo analyses revealed that the most severe degree of
EFE (Grade 4) developed in the most dilated (LVDd (mm),
5.24 ± 0.54 versus 2.51 ± 0.29, 𝑃 < 0.01; LVDs (mm), 2.84 ±
0.50 versus 1.10 ± 0.12, 𝑃 < 0.01) and poorly contractile LVs
(FS (%); 3.15 ± 1.28 versus 25.0 ± 2.77, 𝑃 < 0.01) (Figure 5).
The severity of distention was directly associated with the
amount of EFE.
4. Discussion
In this study, we successfully created an animal model of
EFE by introducing clinical features of evolving human
fetal HLHS which included a combination of immaturity,
stagnation of flow, and distention of the LV through vol-
ume/pressure overload. Our results indicate that the amount
of EFE directly correlates with the severity of LV distention
when added to immaturity and stagnation of intracavitary
flow. These findings shed new light on the underlying
mechanisms of EFE development, which are in line with
clinical observations of fetal patients with aortic stenosis and
impending HLHS development.
Although multiple animal models have produced LV
hypertrophy by introducing left-sided obstruction, none have
been successful in creating EFE [25, 26]. Major limitations
using fetal experimental animals are difficulties in obtaining
survival cases when applying major hemodynamic changes
acutely. Creating aortic stenosis in an early gestational fetus
gradually increases LV end-diastolic pressure but fails to
create abrupt augmentation of LV pressure/volume load,
which we observed in a subgroup of fetuses with aortic
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Figure 2: Postoperative echocardiography. (a) Short axis views of LVs in diastole and systole.The distended LVmodel developed significantly
larger LVs than those in the unloaded LVmodel (∗𝑃 < 0.01, NS: not significant). (b) Apical long axis view of a LV in the distended LVmodel.
An AR jet was detected in a 2D echocardiography with color Doppler.
stenosis and evolving HLHS.Thus, as a consequence, no EFE
developed in these animal models [25].
Fully vascularized cardiac transplantation in small ani-
mals has been established and reliably used to address a wide
variety of issues. Multiple modifications have been attempted
to facilitate construction of the anastomoses, which has been
recognized as a technical challenge and requires a substantial
learning curve to achieve acceptable reproducibility [27].
Using a neonatal rat as a donor would be even more chal-
lenging given the small size and fragility. To overcome this
potential vulnerability of the present model, postoperative
monitoring was imperative. Therefore, we newly developed
a heterotopic femoral heart transplantation model, in which
a transplanted heart was vascularized by the recipient’s
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Figure 3: (a) A representative photograph and slides of the distended LV model. Each shows short axis views of the ventricles. The
endocardium is covered by macroscopically discernible pearly white thick layers of fibroelastosis. Masson’s Trichrome- and Elastica van
Gieson-stained slides depict thick fibrous layers with an abundant collagen deposition (stained in blue) and stratified elastin fibers (black
wavy lines) on the endocardial surface. (b) Representative Hematoxylin and Eosin- and Masson’s Trichrome-stained slides in the unloaded
LVmodel.The LV appears contracted with a thickened myocardial layer. No apparent fibrous tissue develops on the endocardium. (c) A case
with a mural thrombus in the unloaded LVmodel. Masson’s Trichrome-stained slides depict a large mural thrombus occupying the LV cavity.
The mural thrombus has an abundant collagen deposition but no elastin fibers in an Elastica van Gieson-stained slide. Black scale bar, 1mm;
white scale bar, 200𝜇m. (d) Comparison of EFE scores between the distended LV model and the unloaded LV model (∗𝑃 < 0.01).
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Figure 4: In comparison, the distended LV model using a 2-week-old donor. (a) A photograph of a transplanted donor heart in situ. (b)
Representative echo images showing the apical long axis view of the LV. An AR jet was detected in a 2D echocardiography with color Doppler.
(Ao: aorta). (c) Representative Hematoxylin and Eosin- and Masson’s Trichrome-stained slides sectioned along the short axis. Collagen-rich
fibrous layers (stained in blue) are seen in the subendocardial layer of a 2-week-old donor heart. (d) AMasson’s Trichrome-stained slide from
a neonatal donor heart for comparison. Fibrous layers are located on the endocardial surface of the LV. Black scale bar, 1mm; white scale bar,
200 𝜇m.
femoral vessels and placed superficially in a groin pocket.
Unlike the conventional abdominal transplantation model,
thismodelmade the posttransplant heart palpable and visible
via postoperative trans-femoral echocardiography.
In the present study, the unloaded LV model did not
produce significant EFE as indicated by our scoring data.The
discrepancy toward our previously published results may be
attributable to subtle technical differences, such as the way
of placing a stitch, aligning the target vessels, positioning
the posttransplant with possible distortion of the aortic root,
and obtaining optimal hemostasis, given the nature of this
technically demanding and thus fairly surgeon-dependent
procedure. Technical differences resulted in altering degrees
of compromised LV function, which potentially influenced
EFE formation. We addressed this issue by refining our
animal model through incorporation of LV distention, which
provided reproducible degrees of LV dysfunction. Alterna-
tively, it can be attributed to diagnostic challenges with EFE.
A mural thrombus or other nonspecific endocardial fibrosis
could mimic EFE. In particular islet-type patchy fibrosis
on the endocardium is difficult to determine due to the
phenotypical ambiguity and indiscernible elastin fibers.
To fulfill distention of the LV, we introduced AR through
direct damage of the aortic valve. AR mimics the clinical
situation of a distended LV in some impending HLHS cases
but does not occur as a prominent pathophysiologic feature
in human fetuses. Thus, there is the potential that the
direction and velocity of blood flow following AR through
the LV or shear stress applied onto the endocardium could
be completely different. The AR jet might, thereby, directly
injure the endocardium and induce EFE formation regardless
of LV distention. Since EFE in this study is distributed homo-
geneously over the full circumference of the endocardium,
our results indicate that the AR jet does not directly injure
the endocardium. Therefore, direct injury from an AR jet,
whichwould have created spatially variable local lesions, is an
unlikely contributor to EFE formation in this model. Direct
localized endothelial injury could also have been caused by
8 BioMed Research International
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Figure 5: Relationship between LV distention and EFE amount. (a) Representative echo images and Masson’s Trichrome-stained slides
sectioned along the long axis. Mild LV distention created mild EFE (Grade 2) (upper row), whereas severe LV distention created severe EFE
(Grade 4) (lower row). White dots in the echo images delineate the contour of the LV endocardium. Black scale bar, 1mm; white scale bar,
200 𝜇m. (b) Comparison of the LV dimensions and fractional shortenings between Grade 2, 3 EFE cases and Grade 4 EFE cases (∗𝑃 < 0.01).
accidental trauma through the needle used for damaging the
aortic valve leaflet. Initial attempts, in which we used a rigid
thin needle to create AR, resulted in a localized fibrous scar
lesion at the location of the injured endocardium (data not
shown). This technical failure prompted us to use a flexible
ultrathin guide-wire to create AR, which eliminated the risk
of direct injury to the endocardium.
Difficulty in regulating the degree of AR generates differ-
ent degrees of LV distention and results in variable amounts
of EFE formation but at the same time provides a positive
relationship between LV distention and the amount of EFE.
Variable AR amounts also impose a challenge on a direct
comparison between an immature donor group (P 2 to
4) and a relatively mature donor group (2-week-old) since
the severity of LV distention, which is represented by the
size and function of the LV, is not directly comparable.
In addition, susceptibility to distention may vary. However,
the fact that the distended LV model with a 2-week-old
donor created prominent subendocardial fibrosis but no
EFE (Figure 4(c)) indicates that not only distention but also
immaturity plays a key role in this pathological process. To
the best of our knowledge, none of the animal models of
AR using adult subjects have described EFE as a histological
change [28, 29].
It is still controversial whether EFE is a distinct pathologic
entity or a secondary phenomenon caused by stressors on
the heart, such as mechanical overload. In order to explore
benefits and limitations of therapeutic interventions on
BioMed Research International 9
the immature/fetal heart it is imperative to create a robust
animal model of EFE to elucidate the underlying cause
of EFE formation and to determine effective therapeutic
agents targeting EFE. Intuitively, suppression of overgrowth
of fibrotic layers on the endocardium, preferably combined
with the mechanical relief of the distention such as FAV
during the fetal stage, would provide a better chance to use the
LV as systemic ventricle. Indeed, in experienced institutions,
postnatal surgical resection of EFE has been performed in an
attempt to restore and recruit the LV and improved outcome
in selected cases has been reported [30, 31]. However, given
the possibility that EFE is a protective response of the
immature heart from mechanical overload, it might not be
a useful therapeutic target during fetal development.
The current model shows that distention of the ventricle
is one of the important mechanical factors which triggers
the development of EFE in an age-dependent manner. These
findings implicate that a relief of the underlying mechanical
overload such as fetal aortic stenosis is of primary impor-
tance to mitigate EFE formation and exerts the greatest
benefit if performed promptly when themechanical overload
appears. Since immediate relief of the mechanical overload
to prevent EFE formation might not be feasible, alternative
treatment strategies should potentially dissolve or reverse
already present EFE.
5. Conclusions
We present an animal model where we could show that the
distention of the immature LV triggers EFE formation by
introducing morphopathological features of evolving human
fetalHLHS.Thismodel could serve as a robust tool to develop
therapeutic strategies to treat EFE while providing insight
into its pathogenesis.
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